Omada Health, Inc. Common Stock (OMDA) Stock Price
OMDAStock
$17.63−29.31%52W
Market Cap$1.08B
P/E—
PEG Ratio—
Div yield—
Beta1.91
OMDA Share Price Chart
Favorite Metrics
Price vs S&P 500 (26W)31.59%
Price vs S&P 500 (4W)-13.13%
VGM Score42.53
OMDA Earnings Surprise History
| Quarter | Report date | EPS estimate | EPS actual | Surprise |
|---|---|---|---|---|
| Q2 2026 | $0.06 | $0.20 | +219.84%(+$0.13) | |
| Q1 2026 | -$0.04 | $0.05 | +209.88%(+$0.09) | |
| Q4 2025 | $0.03 | $0.16 | +440.33%(+$0.13) | |
| Q3 2025 | -$0.07 | $0.03 | +142.62%(+$0.10) | |
| Q2 2025 | -$0.13 | -$0.05 | +59.14%(+$0.07) |
OMDA Analyst Recommendations
Jun 2026
Jul 2026
Aug 2026
Sep 2026
3.94
3.94
4.00
4.00
Industry Peers — Health Services(21)
| Symbol | Value Score | Growth Score | Momentum Score | P/E Ratio (Annual) | Revenue Growth TTM (YoY) | Operating Margin (TTM) | ROE (TTM) | Price |
|---|---|---|---|---|---|---|---|---|
OMDAOmada Health, Inc. Common Stock | D | B | D | — | 8.3% | -0.8% | 1.8% | $17.63 |
| LFSTLifeStance Health Group, Inc. Common Stock | D | A | B | 464.3x | 61.1% | 4.9% | 3.4% | $11.74 |
| PRVAPrivia Health Group, Inc. Common Stock | C | B | C | 125.5x | 24.1% | 1.9% | 3.8% | $22.52 |
| WGSGeneDx Holdings Corp. Class A Common Stock | F | B | D | — | 25.4% | -21.8% | -38.7% | $63.61 |
| PNTGThe Pennant Group, Inc. Common Stock | D | B | B | 49.4x | 37.9% | 5.7% | 9.5% | $41.87 |
| USPHUS Physical Therapy Inc | C | D | C | 32.3x | 11.3% | 9.4% | 6.8% | $85.71 |
| INNVInnovAge Holding Corp. Common Stock | D | C | C | — | 15.9% | 0.3% | -1.1% | $8.85 |
| PIIIP3 Health Partners Inc. Common Stock | A | C | D | — | 2.8% | -9.9% | 10.3% | $4.14 |
| SRTAStrata Critical Medical, Inc. Class A Common Stock | B | B | C | 9.7x | 18.8% | -8.0% | 14.3% | $4.54 |
| ALPSALPS Group Inc Ordinary Share | — | — | D | — | — | — | — | $0.34 |
| EUDAEUDA Health Holdings Limited Ordinary Shares | C | B | C | — | 66.9% | -36.5% | -1.8% | $15.40 |
About Omada Health, Inc. Common Stock
Omada Health provides a digital-first care platform delivering personalized interventions for cardiometabolic and behavioral health conditions, including diabetes, hypertension, and musculoskeletal disorders. The platform serves employers, health plans, health systems, and pharmacy benefit managers, with specialized support for GLP-1 medication management. By enabling virtual care between clinical visits, Omada generates measurable health outcomes and economic value across its customer base.